Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: May 24, 2019
Date Accepted: Aug 28, 2019

The final, peer-reviewed published version of this preprint can be found here:

The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study

Bollyky JB, Melton ST, Xu T, Painter SL, Knox B

The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study

JMIR Diabetes 2019;4(4):e14799

DOI: 10.2196/14799

PMID: 31593545

PMCID: 6803884

A Cellular-Enabled Glucose Meter Improves Glucose Control For Patients with Diabetes

  • Jennifer B Bollyky; 
  • Stephanie T Melton; 
  • Tong Xu; 
  • Stefanie L Painter; 
  • Brian Knox

ABSTRACT

Background:

Diabetes is a global epidemic affecting approximately 30 million people in the United States. The World Health Organization recommends using technology and telecommunications to improve health care delivery and disease management. The Livongo for Diabetes Program offers a remote monitoring technology with Certified Diabetes Educator outreach.

Objective:

The purpose of this study was to examine health outcomes measured by change in HbA1c, time in target BG range, and depression symptoms for patients enrolled in remote digital diabetes management program in a Diabetes Center of Excellence setting.

Methods:

The impact of the Livongo for Diabetes Program on HbA1c, blood glucose ranges, and depression screening survey results (PHQ-2) was assessed over 12 months in a prospective cohort recruited from the University of South Florida Health Diabetes Home for Healthy Living. Any patient >18 years old with a diagnosis of diabetes was approached for voluntary inclusion into the program. The analysis was a pre-post design for those members enrolled in the study. Data was collected at outpatient clinic visits and remotely through the Livongo glucose meter.

Results:

Eighty-six adults were enrolled into the Livongo for Diabetes program with 49% female, an average age of 50 (standard deviation = 15.0) years, 56% with type 2 diabetes mellitus, and 69% with insulin use. The mean HbA1c drop amongst the group was 0.66% (P=0.03) with all participants showing a decline in HbA1c at 12 months. A 17% decrease of blood glucose checks <70 mg/dL occurred concurrently. Participants with type 2 diabetes not using insulin had blood glucose values within target range (70 to 180 mg/dL) 89% of the time. Participants with type 2 diabetes using insulin were in target range 68% of the time, and type 1 diabetes 58% of the time. Average PHQ-2 scores decreased by 0.56 points during the study period.

Conclusions:

Participants provided with a cellular-enabled blood glucose meter with real-time feedback and access to coaching from a certified diabetes educator in an outpatient clinical setting experienced improved mean glucose values and fewer episodes of hypoglycemia relative to the start of the program.


 Citation

Please cite as:

Bollyky JB, Melton ST, Xu T, Painter SL, Knox B

The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study

JMIR Diabetes 2019;4(4):e14799

DOI: 10.2196/14799

PMID: 31593545

PMCID: 6803884

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.